Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Open accessAbstract
BACKGROUND: In Canada, low awareness of evidence-based interventions for the clinical management of alcohol use disorder exists among health care providers and people who could benefit from care. To address this gap, the Canadian Research Initiative in Substance Misuse convened a national committee to develop a guideline for the clinical management of high-risk drinking and alcohol use disorder. METHODS: Development of this guideline followed the ADAPTE process, building upon the 2019 British Columbia provincial guideline for alcohol use disorder. A national guideline committee (consisting of 36 members with diverse expertise, including academics, clinicians, people with lived and living experiences of alcohol use, and people who self-identified as Indigenous or Métis) selected priority topics, reviewed evidence and reached consensus on the recommendations. We used the Appraisal of Guidelines for Research and Evaluation Instrument (AGREE II) and the Guidelines International Network's Principles for Disclosure of Interests and Management of Conflicts to ensure the guideline met international standards for transparency, high quality and methodological rigour. We rated the final recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool; the recommendations underwent external review by 13 national and international experts and stakeholders. RECOMMENDATIONS: The guideline includes 15 recommendations that cover screening, diagnosis, withdrawal management and ongoing treatment, including psychosocial treatment interventions, pharmacotherapies and community-based programs. The guideline committee identified a need to emphasize both underused interventions that may be beneficial and common prescribing and other practice patterns that are not evidence based and that may potentially worsen alcohol use outcomes. INTERPRETATION: The guideline is intended to be a resource for physicians, policymakers and other clinical and nonclinical personnel, as well as individuals, families and communities affected by alcohol use. The recommendations seek to provide a framework for addressing a large burden of unmet treatment and care needs for alcohol use disorder within Canada in an evidence-based manner.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The recent Canadian guideline on high-risk drinking and AUD management raises concerns regarding the use of SSRIs in individuals with AUD and non-substance-induced Major Depressive Disorder or anxiety disorders.
“the recent Canadian guideline on high-risk drinking and AUD management, which raises concerns regarding the use of SSRIs in individuals with AUD and non-substance-induced Major Depressive Disorder (MDD) or anxiety disorders [59].”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870 · see citing works
Self-citationAGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790 · see citing works
World health statistics 2016 : monitoring health for the SDGs, sustainable development goals
de la Salud, O. M. (2016) · Virtual Defense Library (Ministerio de Defensa) · Cited by 3,358 · see citing works
Patient-centredness: a conceptual framework and review of the empirical literature
Mead, N., & Bower, P. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00098-8 · Cited by 2,993 · see citing works
Zeng, X., Zhang, Y., Kwong, J. S. W., Zhang, C., Li, S., Sun, F., Niu, Y., & Du, L. (2015) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12141 · Cited by 2,082 · see citing works
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665 · see citing works
The alcohol use disorders identification test: an update of research findings
Reinert, D. F., & Allen, J. P. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00295.x · Cited by 1,397 · see citing works
The Australian Guidelines to Reduce Health Risks from Drinking Alcohol
Brussen, K. A. (2010) · Chisholm Health Ethics Bulletin · Cited by 1,083 · see citing works
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923 · see citing works
AGREE II: advancing guideline development, reporting, and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.08.005 · Cited by 758 · see citing works
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650 · see citing works
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580 · see citing works
The Social Epidemiology of Substance Use
Galea, S. (2004) · Epidemiologic Reviews · doi:10.1093/epirev/mxh007 · Cited by 559 · see citing works
Shield, K. D., Manthey, J., Rylett, M., Probst, C., Wettlaufer, A., Parry, C. D. H., & Rehm, J. T. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30231-2 · Cited by 528 · see citing works
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.16789 · Cited by 517 · see citing works
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470 · see citing works
Treatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465 · see citing works
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 420 · see citing works
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1590/s1516-31802010000600014 · Cited by 405 · see citing works
Schünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1885 · Cited by 337 · see citing works
Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000447 · Cited by 315 · see citing works
VELLEMAN, R. D. B., TEMPLETON, L. J., & COPELLO, A. G. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500167478 · Cited by 304 · see citing works
Implementing Anti-Racism Interventions in Healthcare Settings: A Scoping Review
Hassen, N., Lofters, A., Michael, S., Mall, A., Pinto, A. D., & Rackal, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18062993 · Cited by 286 · see citing works
The ASAM principles of addiction medicine
Ries, R. K., Fiellin, D. A., Miller, S. C., & Saitz, R. (2014) · Wolters Kluwer Health eBooks · Cited by 261 · see citing works
Kranzler, H. R., Burleson, J. A., Brown, J., & Babor, T. F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01696.x · Cited by 213 · see citing works
Discrimination and drinking: A systematic review of the evidence
Gilbert, P. A., & Zemore, S. E. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.06.009 · Cited by 210 · see citing works
Mulvaney‐Day, N., Marshall, T., Piscopo, K. D., Korsen, N., Lynch, S. E., Karnell, L. H., Moran, G. E., Daniels, A. S., & Ghose, S. S. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4181-0 · Cited by 201 · see citing works
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
(2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000668 · Cited by 194 · see citing works
Harm reduction therapy: a practice‐friendly review of research
Logan, D. E., & Marlatt, G. A. (2010) · Journal of Clinical Psychology · doi:10.1002/jclp.20669 · Cited by 192 · see citing works
Jones, L., Bates, G., McCoy, E., & Bellis, M. A. (2015) · BMC Public Health · doi:10.1186/s12889-015-1720-7 · Cited by 184 · see citing works
Validity of Brief Screening Instrument for Adolescent Tobacco, Alcohol, and Drug Use
Kelly, S. M., Gryczynski, J., Mitchell, S. G., Kirk, A. S., O’Grady, K. E., & Schwartz, R. P. (2014) · PEDIATRICS · doi:10.1542/peds.2013-2346 · Cited by 165 · see citing works
Munkholm, K., Paludan-Müller, A. S., & Boesen, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024886 · Cited by 151 · see citing works
Guidelines for the Treatment of Alcohol Problems
Haber, P., & Riordan, B. C. (2009) · PsycEXTRA Dataset · doi:10.1037/e674042010-001 · Cited by 149 · see citing works
Vannier, A., Shay, J. E. S., Fomin, V., Patel, S. J., Schaefer, E. A. K., Goodman, R. P., & Luther, J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13014 · Cited by 137 · see citing works
Platt, L., Melendez-Torres, G. J., O'Donnell, A., Bradley, J., Newbury-Birch, D., Kaner, E., & Ashton, C. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011473 · Cited by 136 · see citing works
Maldonado, J. R., Sher, Y. I., Das, S., Hills-Dunlap, K., Frenklach, A., Lolak, S., Talley, R. M., & Neri, E. (2015) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv043 · Cited by 135 · see citing works
Friedmann, P. D., Rose, J. S., Swift, R., Stout, R. L., Millman, R. P., & Stein, M. D. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00742.x · Cited by 116 · see citing works
Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?
Wood, E., Albarqouni, L., Tkachuk, S., Green, C. J., Ahamad, K., Nolan, S., McLean, M., & Klimas, J. (2018) · JAMA · doi:10.1001/jama.2018.10574 · Cited by 114 · see citing works
Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study
Wiesbeck, G. A. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.329 · Cited by 110 · see citing works
Physician Education in Addiction Medicine
Wood, E., Samet, J. H., & Volkow, N. D. (2013) · JAMA · doi:10.1001/jama.2013.280377 · Cited by 106 · see citing works
A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence
Kranzler, H. R., Armeli, S., Tennen, H. A., Covault, J., Feinn, R., Arias, A. J., Pettinati, H. M., & Oncken, C. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820465fa · Cited by 100 · see citing works
Roerecke, M., Gual, A., & Rehm, J. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08379 · Cited by 100 · see citing works
Self-citationCiraulo, D. A., Barlow, D. H., Gulliver, S. B., Farchione, T. J., Morissette, S. B., Kamholz, B. W., Eisenmenger, K., Brown, B., Devine, E. G., Brown, T. A., et al. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.08.003 · Cited by 92 · see citing works
Couple and family involvement in adult mental health treatment: a systematic review
Meis, L. A., Griffin, J. M., Greer, N., Jensen, A. C., MacDonald, R., Carlyle, M., Rutks, I., & Wilt, T. J. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.12.003 · Cited by 92 · see citing works
Levin, F. R., Mariani, J., Brooks, D. J., Pavlicova, M., Nunes, E. V., Agosti, V., Bisaga, A., Sullivan, M. A., & Carpenter, K. M. (2013) · Addiction · doi:10.1111/add.12108 · Cited by 89 · see citing works
Cheng, H., McGuinness, L. A., Elbers, R. G., MacArthur, G. J., Taylor, A., McAleenan, A., Dawson, S., López-López, J. A., Higgins, J. P. T., Cowlishaw, S., et al. (2020) · BMJ · doi:10.1136/bmj.m3934 · Cited by 78 · see citing works
Narrating the journey of sustained recovery from substance use disorder
Stokes, M., Schultz, P., & Alpaslan, A. H. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0167-0 · Cited by 64 · see citing works
Cooper, Z. D., Foltin, R. W., Hart, C. L., Vosburg, S. K., Comer, S. D., & Haney, M. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00461.x · Cited by 62 · see citing works
Antipsychotics for Primary Alcohol Dependence
Kishi, T., Sevy, S. M., Chekuri, R., & Correll, C. U. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r08178 · Cited by 60 · see citing works
Can antipsychotic treatment contribute to drug addiction in schizophrenia?
Samaha, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.008 · Cited by 53 · see citing works
Correlates of benzodiazepine dependence in the N etherlands S tudy of D epression and A nxiety
Manthey, L., Lohbeck, M., Giltay, E. J., van Veena, T., Zitman, F. G., & Penninx, B. W. J. H. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03975.x · Cited by 51 · see citing works
Wakefield, J. C. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12446 · Cited by 50 · see citing works
Modulating tobacco smoking rates by dopaminergic stimulation and blockade
Caskey, N. H., Jarvik, M. E., Wirshing, W. C., Madsen, D. C., Olmstead, R. E., Iwamoto‐Schaap, P. N., Eisenberger, N. I., Huerta, L., & Terrace, S. M. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210153830 · Cited by 47 · see citing works
Stokes, P. R. A., Jokinen, T., Amawi, S. O., Qureshi, M. M., Husain, M. I., Yatham, L. N., Strang, J., & Young, A. H. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720915420 · Cited by 46 · see citing works
Charney, D. A., Heath, L. M., Zikos, E., Palacios‐Boix, J., & Gill, K. J. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12802 · Cited by 45 · see citing works
Zorick, T. S., Sugar, C. A., Hellemann, G., SHOPTAW, S. J., & London, E. D. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.04.015 · Cited by 42 · see citing works
Canadian Guidelines on Alcohol Use Disorder Among Older Adults
Butt, P. R., White-Campbell, M., Canham, S. L., Johnston, A. D., Indome, E. O., Purcell, B., Tung, J., & Bussel, L. V. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.425 · Cited by 42 · see citing works
Barrio, P., & Gual, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109641 · Cited by 39 · see citing works
Lange, S., Shield, K. D., Monteiro, M. G., & Rehm, J. T. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14171 · Cited by 38 · see citing works
Bender, S., Scherbaum, N., Soyka, M., Rüther, E., Mann, K. F., & Gastpar, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007164 · Cited by 34 · see citing works
First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.
Spithoff, S. M., Turner, S., Gomes, T., Martins, D., & Singh, S. (2017) · Europe PMC (PubMed Central) · Cited by 34 · see citing works
(2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371969 · Cited by 32 · see citing works
Increased alcohol consumption in rats after subchronic antidepressant treatment
Alén, F., Orío, L., Gorriti, M. Á., de Heras, R. G., Ramírez-López, M. T., Pozo, M. A., & de Fonseca, F. R. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000217 · Cited by 22 · see citing works
Ninety-three cases of alcohol dependence following SSRI treatment
Brookwell, L., Hogan, C., Healy, D., & Mangin, D. A. (2014) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-140616 · Cited by 21 · see citing works
Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study
Konrad, G., Leong, C., Bolton, J. M., Prior, H. J., Paillé, M. T., Nepon, J., Singal, D., Ekuma, O., Enns, J. E., & Nickel, N. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257025 · Cited by 17 · see citing works
Watson, J. M., Toner, P., Day, E., Back, D., Brady, L., Fairhurst, C. M., Renwick, C., Templeton, L. J., Akhtar, S., Lloyd, C., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21150 · Cited by 16 · see citing works
Unhelpful Prescribing in Alcohol Use Disorder: Risk and Averting Risk
Chick, J. (2018) · Alcohol and Alcoholism · doi:10.1093/alcalc/agy090 · Cited by 15 · see citing works
Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C. (2019) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180046 · Cited by 14 · see citing works
Characterization of benzodiazepine misuse and comorbidities in patients with alcohol use disorder
Lopez, E., Jeanne, G., Lefort, L.-H., Autissier, C., Picot, M., Peyrière, H., & Donnadieu‐Rigole, H. (2021) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12678 · Cited by 13 · see citing works
Validity of Brief Screening Instrument for Adolescent Tobacco, Alcohol, and Drug Use
(2014) · PEDIATRICS · doi:10.1542/peds.2013-2346d · Cited by 7 · see citing works
Lange, S., Shield, K. D., Monteiro, M. G., & Rehm, J. T. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3360110 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 73 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [1]Pearson C Janz T Ali J. Mental and substance use disorders in Canada. Ottawa: Health at a Glance — Statistics Canada; 2015. Cat. no. 82-624-X. Available: https://www150.statcan.gc.ca/n1/pub/82-624-x/2013001/article/11855-eng.htm (accessed 2023 May 10).
- [17]O’Connor EA Perdue LA Senger CA. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality; 2018. Available: https://www.uspreventiveservicestaskforce.org/home/getfilebytoken/h6SEK5cYmTKRECLtj3QxyA (accessed 2023 May 10). 30525341
Cited by
Sorted by citations
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83 · see citing works
“This complexity is further underscored by the recent Canadian guideline on high-risk drinking and AUD management, which raises concerns regarding the use of SSRIs in individuals with AUD and non-substance-induced Major Depressive Disorder (MDD) or anxiety disorders [59].”
BackgroundA public health perspective on mitigating the global burden of chronic liver disease
Balakrishnan, M., & Rehm, J. T. (2023) · Hepatology · doi:10.1097/hep.0000000000000679 · Cited by 41 · see citing works
Emerging strategies and clinical recommendations for the management of novel depression subtypes
Chiappini, S., Sampogna, G., Ventriglio, A., Menculini, G., Ricci, V., Pettorruso, M., Volpe, U., & Martinotti, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2470973 · Cited by 22 · see citing works
Does This Patient Have Alcohol Use Disorder?
Wood, E., Pan, J., Cui, Z., Bach, P., Dennis, B. B., Nolan, S., & Socias, M. E. (2024) · JAMA · doi:10.1001/jama.2024.3101 · Cited by 22 · see citing works
Rehm, J. T., Assanangkornchai, S., Hendershot, C. S., Franklin, A., Neufeld, M., Hassan, A. S., & Shield, K. D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01496-5 · Cited by 23 · see citing works
Drug safety in older patients with alcohol use disorder: a retrospective cohort study
Schröder, S., Westhoff, M. S., Pfister, T., Seifert, J., Bleich, S., Koop, F., Proskynitopoulos, P. J., Glahn, A., & Heck, J. (2024) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253241232563 · Cited by 12 · see citing works
Harms and costs of proposed changes in how alcohol is sold in Ontario
Giesbrecht, N., & Myran, D. T. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.240069 · Cited by 12 · see citing works
Triple network resting-state functional connectivity patterns of alcohol heavy drinking
Elsayed, M., Marsden, E., Hargreaves, T., Syan, S. K., MacKillop, J. M., & Amlung, M. T. (2024) · Alcohol and Alcoholism · doi:10.1093/alcalc/agae056 · Cited by 10 · see citing works
Quelch, D. R., Lingford-Hughes, A. R., John, B., Nutt, D., Bradberry, S., & Roderique‐Davies, G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241294005 · Cited by 10 · see citing works
Wong, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_36 · Cited by 9 · see citing works
Zhang, X., Chen, Y., Hu, W., Lu, S., Yu, H., & Sun, Y. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2543524 · Cited by 9 · see citing works
Bahji, A., Danilewitz, M., Sloan, M. E., Tang, V. M., & Crockford, D. N. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.149917-l · Cited by 8 · see citing works
Alcohol Use Disorder Diagnoses Among Individuals Who Take HIV Preexposure Prophylaxis
Avanceña, A. L. V., Okoye, G., Yokananth, R., Norwood, A., & Schnarrs, P. W. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.7295 · Cited by 7 · see citing works
Schröder, S., Massarou, C., Pfister, T., Bleich, S., Proskynitopoulos, P. J., Heck, J., Westhoff, M. S., & Glahn, A. (2025) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241311214 · Cited by 6 · see citing works
Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review
Iqbal, M., Modi, P., Sehgal, K., Costa, G. P. A., Bhattacharya, G., Nero, N., Siddiqui, J., Weleff, J., & Anand, A. (2026) · CNS Drugs · doi:10.1007/s40263-025-01254-9 · Cited by 7 · see citing works
Teixeira, J., Pinheiro, M., Pereira, G. Á., Nogueira, P., Guerreiro, M., Castanho, M. A. R. B., & do Couto, F. S. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15302 · Cited by 6 · see citing works
Addressing the risks of antidepressants among people with alcohol use disorders
Wood, E., & Rehm, J. T. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.150095-l · Cited by 6 · see citing works
Dobashi, S., Kawaida, K., Saito, G., Owaki, Y., & Yoshimoto, H. (2024) · BMC Medicine · doi:10.1186/s12916-024-03641-3 · Cited by 5 · see citing works
Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy
Gandhi, P., Healy, D., & Bozinoff, N. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.231015 · Cited by 4 · see citing works
Rethinking trazodone for insomnia in alcohol use disorder
Pan, J., Rehm, J. T., & Wood, E. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00552-3 · Cited by 4 · see citing works
Gravely, S. M. L., Driezen, P., Shahab, L., McClure, E. A., Hyland, A. J., Cummings, K. M., East, K. A., Chan, G., Walsh, H., Benowitz, N. L., et al. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01214-8 · Cited by 4 · see citing works
Elefante, J., Lu, C., & Bach, P. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.150034-l · Cited by 4 · see citing works
A Case of Prolonged Wernicke's Encephalopathy Successfully Treated With Long-Term High-Dose Thiamine
Mizui, R., Takada, R., Ikuno, K., Araki, S., & Okada, T. (2025) · Cureus · doi:10.7759/cureus.85163 · Cited by 3 · see citing works
Praharaj, S. K., Menon, V., & Ameen, S. (2025) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_692_24 · Cited by 6 · see citing works
Tan, C., Qiao, M., Chang, J., Chen, S.-M., & Wang, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095435 · Cited by 3 · see citing works
Morin, K. A., Hill, L. C., Knowlan, S., Bodson, A., Nikodem, P., Aubin, N., Marsh, D. C., & Leary, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325083 · Cited by 3 · see citing works
Ross, H., Kurbatfinski, S., & Szelest, I. (2024) · Healthcare Management Forum · doi:10.1177/08404704241229973 · Cited by 3 · see citing works
Using illicit drugs alone in Vancouver, Canada: a gender-based analysis
Gallant, K., Hayashi, K., Sayre, E. C., Choi, J., Mansoor, M., & Kerr, T. H. (2025) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-025-00637-x · Cited by 3 · see citing works
Noël, C., Armiento, C., & Scharf, D. M. (2025) · Journal of American College Health · doi:10.1080/07448481.2025.2520371 · Cited by 2 · see citing works
Russell, C., Wiese, J. L., Ruocco, A. C., Bozinoff, N., González, R. R. R., Jennings, S., Leyton, M., Nikolova, Y. S., Orson, J., Potenza, M. N., et al. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70154 · Cited by 2 · see citing works
Chandran, A., Veldhuizen, S., Mehra, K., Rodak, T., Vagharfard, D., Pham, M., Zawertailo, L. A., Rehm, J. T., Hendershot, C. S., Selby, P., et al. (2025) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2025.2554182 · Cited by 2 · see citing works
Yan, L., Ji, C., Xia, L.-P., Sun, W., Shi, J.-Q., & Wu, X.-D. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s538359 · Cited by 2 · see citing works
Pan, J., Xu, K. Y., & Wood, E. (2025) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001475 · Cited by 2 · see citing works
Serotonin Syndrome Masquerading as Alcohol Withdrawal: A Case Report
Choi, M., Wang, X., Singh, M., & Weleff, J. (2025) · Journal of Addictive Diseases · doi:10.1080/10550887.2025.2545649 · Cited by 1 · see citing works
Concurrent Disorders: Treatment of Comorbid Alcohol Use Disorder and Major Depressive Disorder
Primeau, V., Danilewitz, M., Crockford, D. N., Kleinman, R. A., Jutras‐Aswad, D., & Bahji, A. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251409626 · Cited by 1 · see citing works
Tsang, V. W. L., Walia, T., Sattler, K., & Kryskow, P. (2026) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000003665 · Cited by 1 · see citing works
Singh, N., Lee, E., Kulai, T. B., Ghosh, S. M., Tandon, P., Flemming, J., Tsien, C. D., & Faisal, N. (2026) · Canadian Liver Journal · doi:10.3138/canlivj-2025-0016 · Cited by 1 · see citing works
Busch, A. B., Hodgkin, D., Kennedy‐Hendricks, A., Ritter, G. A., Uscher‐Pines, L., Horgan, C. M., & Huskamp, H. A. (2026) · Addiction · doi:10.1111/add.70498 · Cited by 1 · see citing works
Review of Guidelines on Clonidine for Various Indications
CADTH (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.955 · Cited by 1 · see citing works
Wood, E., & Rehm, J. T. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-02179 · Cited by 1 · see citing works
Gandhi, P., Healy, D., & Bozinoff, N. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.231015-f
Bahji, A., Danilewitz, M., Sloan, M. E., Tang, V. M., & Crockford, D. N. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.149917-l-f
Wood, E., & Rehm, J. T. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.150095-l-f
Elefante, R. J. O., Lu, C., & Bach, P. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.150034-l-f
Wiggins, M., Smith, A. M., & Helsabeck, N. P. (2024) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903241271273
Healy, D. (2024) · Ethical Human Psychology and Psychiatry · doi:10.1891/ehpp-2023-0024
Addictions and Substance Misuse
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg004.pub2
Crepeault, H., Cowan, N., Socias, M. E., Riazi, N., Knill, A., Khela, A., Wood, E., & Ti, L. (2025) · Drug and Alcohol Review · doi:10.1111/dar.14075
Bahji, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00661-8
Giannakakis, S.-M., Talbot, A., Sokoloff, C., Nitulescu, R., & Panchadsaram, T. (2025) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000238
Wynne, W., Iacono, A., Yang, J. Y., Hamzat, B., Leece, P., Kolla, G., Boyd, R., Bozinoff, N., Franklyn, M., Shearer, D., et al. (2025) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaf055
Trends, timing, and predictors of alcohol use disorder treatment among US adult cancer survivors
Lai, J., Avanceña, A. L. V., Nguyen, M. H. K., Zigler, C. M., Velasquez, M. M., Frei, C. R., & Pignone, M. P. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70033
Pinheiro, R. V. B., Correia, T., de Oliveira, H. A., & Wagner, G. A. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02889-x
Avoiding anticholinergic burden in neuropsychiatric treatments comorbid with alcohol use disorder
Segura-Ulate, I. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2025-0342
Dobashi, S., Kawaida, K., Saito, G., Owaki, Y., & Yoshimoto, H. (2024) · Figshare · doi:10.6084/m9.figshare.27132737
The ongoing debate about the association between benzodiazepines and dementia
Legrand, D., Roberge, P., & Bocti, C. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125737
Treatment of Methamphetamine Use Disorder
Wood, E., & Rehm, J. T. (2026) · JAMA · doi:10.1001/jama.2025.22277
Heighton, J. N., Lu, C., Contreras-Domínguez, V., & Wooller, K. (2026) · Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000262
Effects of Selective Serotonin Reuptake Inhibitors on Sensory Systems and Mental States
Healy, D. (2026) · Ethical Human Psychology and Psychiatry · doi:10.1891/ehpp-2025-0029
Concurrent (Dual) Disorder Management Guidelines: Systematic Review Update
Hakobyan, S., Allan, Z., Lee-Cheong, S., Adorjan, K., Falkai, P., & Schütz, C. G. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083123
Mekonnen, A. (2026) · American Journal on Addictions · doi:10.1111/ajad.70159
A review on the sachetization of alcohol and its associated risks in Nigeria
Adeyemi, W. J., & Odu, J. O. (2026) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_169_25 · Cited by 1 · see citing works
New Avenues in Adjunctive Pharmacotherapy for Substance Use Disorders
Crockford, D. N., & Bahji, A. (2026) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000276
Piret, E. M., Palis, H., Crabtree, A., Choi, J., DeBeck, K., Hayashi, K., Law, M. R., & Milloy, M. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70186
Ho, C., Dhillon, H., Mitropoulos, A., Flanagan, E., Phan, T. S., Abasszade, J. H., Tse, J., Xia, B., Williams, K., Gondal, F., et al. (2026) · Internal Medicine Journal · doi:10.1111/imj.70539
Chandran, A., Veldhuizen, S., Mehra, K., Zawertailo, L. A., Rehm, J. T., Hendershot, C. S., Selby, P. L., & Minian, N. (2026) · JMIR Formative Research · doi:10.2196/88996
Zuidhof, A., Fasick, D., Smart, R., Bai, P., Hobenshield, L., Hair, H., Curran, J., Baldwin, N., Lappalainen, L., Kelly, J., et al. (2026) · Canadian Journal of Emergency Medicine · doi:10.1007/s43678-026-01206-2
Implementing Evidence-Based Care for Alcohol Use Disorder
Hadland, S. E., Dennis, B. B., & Wood, E. (2026) · NEJM Evidence · doi:10.1056/evidra2500065
Wood, E., Rehm, J. T., Perry, T. L., Menkes, D. B., Poulin, G., Lim, R., Healy, D., Foll, B. L., & Bruneau, J. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261468911
Hayward, B., Herbert, S. E., Sharpe, S., Silailai, L., Pomare, H., Eydt, E., & Tangaere, K. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006893
Raising the Bar for Withdrawal Management: A Patient Centered Path Forward
Danovitch, I., & Boyle, M. P. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001767
Prince, R., Steman, T., Hagen, E. V., Johnson, A. L., Zhang, Y., & Hamilton, T. J. (2026) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2026.1924496
McNeely, C., Tawil, Y., Cahill, T. M., & Lu, C. (2026) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000282
Update der S3-Leitlinie „Screening, Diagnose und Behandlung alkoholbezogener Störungen“
Kiefer, F., Batra, A., Bischof, A., Bischof, G., Borlak, F., Geyer, D., Köhnke, M., Lenz, B., Lindenmeyer, J., Preuss, U. W., et al. (2026) · Der Nervenarzt · doi:10.1007/s00115-026-02026-6
- Authors
- Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., Chase, C., Halpape, K., Lim, R., Kealey, T., & Rehm, J.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Wood, Evan
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Impact Inc.
- Published
- 2023-10-15
- Volume
- 195
- Issue
- 40
- Pages
- E1364-E1379
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- PMC
- PMC10581718
- OpenAlex
- W4387671486
- Cited by
- 74
- References
- 73
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 21 · 2023: 3
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Canadian Medical Association Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Health Canada
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- alcoholism, hazardous drinking, clinical management, alcohol screening, alcohol detoxification, psychosocial interventions, pharmacotherapy, community-based programs, evidence-based interventions, guideline recommendations, Canada
- MeSH terms
- Alcohol Drinking, Alcoholism, British Columbia, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review